Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowSFG Quarterly Activities/Appendix 4CCash Flow Report
Just nowBSA Announces On-Market Share Buy-Back
Just nowPlacement
Just nowMarch 2026 Quarterly Activities & Cashflow Report
Just nowQ3 FY26 Activities Report and Appendix 4C
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc.

About

Calidi Biotherapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 21 2026
Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
Apr 20 2026
Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
Apr 15 2026
Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
Apr 14 2026
Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Apr 7 2026
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy

Community Chat

Ask AI

6ix6ix